AU539531B2 - Immunochemical assay for prostatic acid phosphatase - Google Patents

Immunochemical assay for prostatic acid phosphatase

Info

Publication number
AU539531B2
AU539531B2 AU85051/82A AU8505182A AU539531B2 AU 539531 B2 AU539531 B2 AU 539531B2 AU 85051/82 A AU85051/82 A AU 85051/82A AU 8505182 A AU8505182 A AU 8505182A AU 539531 B2 AU539531 B2 AU 539531B2
Authority
AU
Australia
Prior art keywords
antibody
isoenzyme
precipitate
sample
acid phosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU85051/82A
Other versions
AU8505182A (en
Inventor
Magdalena Usategui Gomez
Hans Jacob Hager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU8505182A publication Critical patent/AU8505182A/en
Application granted granted Critical
Publication of AU539531B2 publication Critical patent/AU539531B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Amplifiers (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. Claims for the Contracting States BE, CH, DE, FR, GB, IT, LI, NL, SE A process for determining the amount of prostatic acid phosphatase isoenzyme in a biological fluid sample, characterized by a) incubating the sample with (i) a soluble first antibody which selectively binds immunologically to the isoenzyme in the sample without inhibiting the enzymatic activity of this isoenzyme, and (ii) an insolubilized antibody formed by coupling this second antibody to amylose whereby the second antibody selectively binds immunologically to the first antibody without inhibiting the enzymatic activity of the isoenzyme, to obtain a precipitate of a mixture of immunocomplexes which contain isoenzyme-first antibody-second antibody and first antibody-second antibody, and b) isolating the precipitate containing the immunocomplexes and c) measuring the isoenzyme activity in the precipitate. 1. Claims for the Contracting State AT A process for determining the amount of prostatic acid phosphatase isoenzyme in a biological fluid sample, characterized by a) incubating the sample with (i) a soluble first antibody which selectively binds immunologically to the isoenzyme in the sample without inhibiting the enzymatic activity of this isoenzyme, and (ii) an insolubilized antibody formed by coupling this second antibody to amylose, whereby the second antibody selectively binds immunologically to the first antibody without inhibiting the enzymatic activity of the isoenzyme, to obtain a precipitate of a mixture of immunocomplexes which contain isoenzyme-first antibody-second antibody and first antibody-second antibody, and b) isolating the precipitate containing the immunocomplexes and c) measuring the isoenzyme activity in the precipitate.
AU85051/82A 1981-06-22 1982-06-21 Immunochemical assay for prostatic acid phosphatase Ceased AU539531B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27622381A 1981-06-22 1981-06-22
US276223 1994-07-15

Publications (2)

Publication Number Publication Date
AU8505182A AU8505182A (en) 1983-01-06
AU539531B2 true AU539531B2 (en) 1984-10-04

Family

ID=23055717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85051/82A Ceased AU539531B2 (en) 1981-06-22 1982-06-21 Immunochemical assay for prostatic acid phosphatase

Country Status (10)

Country Link
EP (1) EP0068291B1 (en)
JP (1) JPS585661A (en)
AT (1) ATE16407T1 (en)
AU (1) AU539531B2 (en)
CA (1) CA1185525A (en)
DE (1) DE3267265D1 (en)
DK (1) DK261282A (en)
ES (1) ES513286A0 (en)
FI (1) FI821821A (en)
NO (1) NO822067L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US6942862B2 (en) 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
CN103808712B (en) * 2012-11-05 2017-12-19 深圳迈瑞生物医疗电子股份有限公司 A kind of liquid reagent box and detection method for acid phosphatase detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048298A (en) * 1975-02-25 1977-09-13 Rohm And Haas Company Solid phase double-antibody radioimmunoassay procedure
US4224406A (en) * 1978-02-27 1980-09-23 Hoffmann-La Roche Inc. Immunochemical LDH1 assay
US4260678A (en) * 1979-02-23 1981-04-07 Corning Glass Works Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
DE2952478A1 (en) * 1979-12-27 1981-07-30 Merck Patent Gmbh, 6100 Darmstadt METHOD AND MEANS FOR THE IMMUNOLOGICAL DETERMINATION OF ENZYMES

Also Published As

Publication number Publication date
NO822067L (en) 1982-12-23
EP0068291A1 (en) 1983-01-05
DE3267265D1 (en) 1985-12-12
ES8307378A1 (en) 1983-07-01
DK261282A (en) 1982-12-23
CA1185525A (en) 1985-04-16
ATE16407T1 (en) 1985-11-15
AU8505182A (en) 1983-01-06
FI821821A (en) 1982-12-23
JPS585661A (en) 1983-01-13
FI821821A0 (en) 1982-05-21
ES513286A0 (en) 1983-07-01
EP0068291B1 (en) 1985-11-06

Similar Documents

Publication Publication Date Title
FR2602592B1 (en) USE OF THE ENZYMATIC XANTHINE-OXYDASE SYSTEM IN IMMUNOALYSIS, CORRESPONDING ASSAY PROCESSES AND REAGENT PACKAGES NECESSARY FOR THE IMPLEMENTATION OF THESE PROCESSES.
ZA877719B (en) Immunoassay based on two enzyme inhibition system
GB9212302D0 (en) Method for improving measurement precision in evanescent wave optical biosensor assays
NO941781L (en) Non-radioactive immunoassay
ES2063821T3 (en) REAGENT COMPOSITION INCLUDING AN ENZYME GIVER.
AU559469B2 (en) Single incubation immunochemical assay
ES8304207A1 (en) Immunochemical assay for creatine kinase-MB isoenzyme
AU635518B2 (en) Assay for bone alkaline phospatase
ATE37199T1 (en) ENZYMATIC DETERMINATION OF UREA.
AU539531B2 (en) Immunochemical assay for prostatic acid phosphatase
DE3473475D1 (en) Process for determining substrate or enzymatic activity
ES537835A0 (en) PROCEDURE FOR THE SPECIFIC DETERMINATION OF EXISTING PANCREATIC A-AMYLASE NEXT TO SALIVA A-AMYLASE
Choe et al. Immunoenzyme assay for human prostatic acid phosphatase
AU561326B2 (en) Specific determination of pancreatic alpha amylase
ATE78599T1 (en) PROCEDURE FOR DETERMINING AND COUNTING PARTICULATE ANTIGENS IN A LIQUID SAMPLE, PARTICULARLY OF CLOSTRIDIUM BUTYRIC SporeS IN MILK.
ES481516A1 (en) Test means and assay for deter- mining the urea content of fluids
AU5057785A (en) A method for determining a ligand
EP0379347A3 (en) Enzyme-labeled receptor composition, diagnostic kit and use in method to determine a ligand